← Open Payments lookup

KATE NEMECEK: Open Payments

NPI 1326596602 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,973 in 82 payments from 20 companies in 2025. Trend: 2023 $899 · 2024 $1,211 · 2025 $1,973

Food & beverage: $1,899Education: $74
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$273
Regeneron Healthcare Solutions, Inc.11$257
Amgen Inc.9$191
Takeda Pharmaceuticals U.S.A., Inc.7$190
GENZYME CORPORATION14$182
KYOWA KIRIN, INC.3$160
GlaxoSmithKline, LLC.12$151
Novartis Pharmaceuticals Corporation4$113
BioCryst US Sales Co., LLC3$87
MAYNE PHARMA COMMERCIAL LLC2$68

Products named: DUPIXENT, TEZSPIRE, CUVITRU, NUCALA, ORLADEYO, RUCONEST, ORALAIR, Sajazir.

Industry payments across CA — which companies pay providers there.